Jean Mah

Principal Applicant
Pediatrics and Clinical Neurosciences Professor at the Cumming School of Medicine
Pediatric Neurologist and the Director of the Pediatric Neuromuscular Program at the Alberta Children’s Hospital
NMD4C Involvement: Pillar 2: Clinical Research, Theme 5: Open Science
Biography
Dr. Jean Mah is a pediatric neurologist and the director of the Pediatric Neuromuscular Program at the Alberta Children’s Hospital in Calgary, Alberta, Canada. She is a Professor of Pediatrics and Clinical Neurosciences at the Cumming School of Medicine, University of Calgary. She is currently involved in multicenter clinical research studies related to pediatric neuromuscular diseases.
Recent Publications
Price, TR, Mah, JK. Reviewer Comment on Slayter et al. "An Exploratory 12-Month Observational Study of Adults with Spinal Muscular Atrophy: Learning from Our Tools". Can J Neurol Sci. 2025. 1 PMID:41039820
Iraqi, I, Ng, P, Chen, X, Cushen, N, Gottowik, J, Herzig, D et al.. Feasibility of a Home-Based Exergaming Intervention for Youth With Spinal Muscular Atrophy. Muscle Nerve. 2025. PMID:40990108
Schiava, M, Dang, UJ, Wood, C, Wong, SC, Ward, LM, Lofra, RM et al.. Height, weight, and body mass index trajectories and their correlation with functional outcome assessments in boys with Duchenne muscular dystrophy. Dev Med Child Neurol. 2025. PMID:40887311
McDonald, CM, Guglieri, M, Vučinić, D, Acsadi, G, Brandsema, JF, Bruno, C et al.. Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons. Ann Clin Transl Neurol. 2025. PMID:40830818
Mah, JK. Therapeutic options for Duchenne muscular dystrophy: hope or hype?. Ther Adv Neurol Disord. 2025.18 17562864251346326 PMID:40547866
Gauvreau, G, Behlim, T, Ng, P, Hodgkinson, V, Selby, K, Mah, JK et al.. Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen. Can J Neurol Sci. 2025. 1-8 PMID:40357918
Tsampalieros, A, McKim, D, Barrowman, N, Bijelic, V, Mah, JK, McMillan, HJ et al.. Lung Volume Recruitment and Quality of Life in Duchenne Muscular Dystrophy: Secondary Analysis of the STEADFAST Randomized Controlled Trial. Ann Am Thorac Soc. 2025.22 (8)1193-1200 PMID:40185084
Qian, C, Klimchak, AC, Szabo, SM, Gooch, KL, Dragan, R, Prior, HJ et al.. Longitudinal Outcomes Among Patients With Duchenne Muscular Dystrophy: A Canadian Retrospective Population-Based Study. Muscle Nerve. 2025.71 (6)955-962 PMID:39945205
McMillan, HJ, Gonorazky, H, Campbell, C, Chrestian, N, Crone, M, Dowling, JJ et al.. Equitable Access to Disease-Modifying Therapies for Canadian Children with SMA and Four SMN2 Copies. Can J Neurol Sci. 2024. 1-3 PMID:39534980
Grasso, EA, Bloy, L, Kaplan, P, Bar-Or, A, Yeh, EA, Arnold, DL et al.. Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2024.11 (6)e200319 PMID:39442038
See more on PubMed